Clovis writes a $20 million check payable to the SEC, hoping to rid itself of the lingering roci probe

Clovis Oncology $CLVS wants to put the SEC’s nagging questions about the way it handled its controversial roci data to bed. And they’re willing to pay $20 million to make that headache go away.